Michael Green
Guy's and St Thomas' NHS Foundation Trust
4 Papers
Michael Green is an academic researcher from Guy's and St Thomas' NHS Foundation Trust. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis
Nick Powell,Nick Powell,Hajir Ibraheim,Hajir Ibraheim,Tim Raine,Richard A Speight,Sophie Papa,Oliver Brain,Michael Green,Mark A Samaan,Lavinia Spain,Nadia Yousaf,Nikki Hunter,Lucy Eldridge,Polychronis Pavlidis,Peter M. Irving,Bu'Hussain Hayee,Samra Turajlic,James Larkin,James O. Lindsay,Martin Gore +20 more
TL;DR: This British Society of Gastroenterology endorsed guidance document has developed a consensus framework for the investigation and management of immune checkpoint inhibitor-induced enterocolitis, which results in off-target immune-mediated injury and organ dysfunction.
42
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
Ahmad A Sherbini,James M. Gwinnutt,Adedeji David Adebajo,Khalid Ahmed,A G Al-Ansari,Roshan Amarasena,Marwan Bukhari,M. Callan,Easwaradhas G Chelliah,Hector Chinoy,Annie Cooper,Bhaskar Dasgupta,Martin Davis,James N. Galloway,Andrew Gough,Michael Green,Nicola J. Gullick,J. Hamilton,W Hassan,Samantha L. Hider,Kimme L. Hyrich,Sanjeet Kamath,Susan Knight,SE Lane,Martin Lee,Sarah Levy,Lizzy Macphie,C. Marguerie,Tom Marshall,Catherine J Mathews,Frank McKenna,Sophia M. Naz,Mark G. Perry,Louise C. Pollard,Brian Quilty,Lindsay Robertson,D.K. Roy,Paul Sanders,Vadivelu Saravanan,David Scott,Gillian L F Smith,Richard D. Smith,Deborah P M Symmons,Lee Suan Teh,N. Viner,Suzanne M M Verstappen +45 more
TL;DR: Prevalence rates and baseline predictors of adverse events (AEs) over the first year of treatment in patients with RA starting MTX were estimated to help patients make informed decisions whether to start MTX, potentially increasing adherence to treatment.
19
Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitis.
TL;DR: Two cancer patients with ICPi-induced colitis who had isolated histoloigical features of colitis in the absence of macroscopic disease are described and induced with the topical steroid preparation, beclometasone dipropionate (Clipper), with no adverse effects.
Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study
R. Witkam,James M. Gwinnutt,Jennifer Humphreys,Suzanne M M Verstappen,Adedeji David Adebajo,Khalid Ahmed,A G Al-Ansari,Roshan Amarasena,Marwan Bukhari,M. Callan,Easwaradhas G Chelliah,Hector Chinoy,Annie Cooper,Bhaskar Dasgupta,Martin Davis,James N. Galloway,Andrew Gough,Michael Green,Nicola J. Gullick,J. Hamilton,W Hassan,Samantha L. Hider,Kimme L. Hyrich,Sanjeet Kamath,Susan Knight,SE Lane,Martin Lee,Sarah Levy,Lizzy Macphie,C. Marguerie,Tom Marshall,Catherine J Mathews,Frank McKenna,Sophia M. Naz,Mark G. Perry,Louise C. Pollard,Brian Quilty,Lindsay Robertson,D.K. Roy,Paul Sanders,Vadivelu Saravanan,David Scott,Gillian S. Smith,Richard D. Smith,Deborah P M Symmons,Lee Suan Teh,N. Viner +46 more
TL;DR: In this article , the authors investigated the relationship between deprivation and obesity with self-reported disability and disease activity in people with RA, and determined whether BMI mediates the relationships between area-level deprivation and these outcomes.